This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Jack and Jill Expectorant
- Starting date:
- January 31, 2013
- Posting date:
- February 28, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-23779
Recalled Products
A. Jack and Jill Expectorant
Reason
The child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed when the tamper-evident seal is still in place.
Depth of distribution
Wholesalers and pharmacies across Canada.
Affected products
A. Jack and Jill Expectorant
DIN, NPN, DIN-HIM
DIN 02350084Dosage form
Syrup
Strength
Guaifenesin 100 mg / 10 mL
Lot or serial number
All lots with expiry dates up to June 2014
Companies
- Recalling Firm
-
Novartis Consumer Health Canada Inc.
Suite 205, West Tower 2233 Argentia Road
Mississauga
L5N 2X7
Ontario
CANADA
- Marketing Authorization Holder
-
The Buckley's Company
205 - 2233 Argentia Rd, West Tower
Mississauga
L5N 2X7
Ontario
CANADA